| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1352880 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of COL6A1 mRNA | CTD | PMID:22079256 |
| (S)-nicotine | multiple interactions | ISO | RGD:1558231 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of COL6A1 mRNA; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | RGD:1558231 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of COL6A1 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:1558231 | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of COL6A1 mRNA]; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1558231 | 6480464 | Ethinyl Estradiol results in increased expression of COL6A1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1558231 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1558231 | 6480464 | Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of COL6A1 mRNA] | CTD | PMID:16977382 |
| 17beta-estradiol | increases expression | ISO | RGD:1352880 | 6480464 | Estradiol results in increased expression of COL6A1 mRNA | CTD | PMID:23019147 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:1558231 | 6480464 | Dihydrotestosterone results in decreased expression of COL6A1 mRNA | CTD | PMID:17023530 |
| 2,2,2-tetramine | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A1 protein] | CTD | PMID:19634143 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1558231 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1558231 | 6480464 | Tetrachlorodibenzodioxin affects the expression of COL6A1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1352880 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of COL6A1 mRNA | CTD | PMID:12377990 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1558231 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of COL6A1 mRNA | CTD | PMID:16120747 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1558231 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of COL6A1 mRNA | CTD | PMID:18648102 |
| 9-cis-retinoic acid | decreases expression | ISO | RGD:1352880 | 6480464 | alitretinoin results in decreased expression of COL6A1 mRNA | CTD | PMID:15982314 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1352880 | 6480464 | Tretinoin metabolite results in decreased expression of COL6A1 mRNA; more ... | CTD | PMID:15982314 |
| azelastine | decreases expression | ISO | RGD:1352880 | 6480464 | azelastine results in decreased expression of COL6A1 mRNA | CTD | PMID:8919039 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1558231 | 6480464 | Benzo(a)pyrene results in decreased expression of COL6A1 mRNA | CTD | PMID:15034205 |
| cadmium dichloride | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL6A1 mRNA | CTD | PMID:19840844 |
| choline | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA | CTD | PMID:20938992 |
| choline | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA | CTD | PMID:20548288 PMID:20938992 |
| copper(2+) sulfate | increases expression | ISO | RGD:1352880 | 6480464 | Copper Sulfate results in increased expression of COL6A1 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | ISO | RGD:1352880 | 6480464 | Cyclosporine results in decreased expression of COL6A1 mRNA | CTD | PMID:20106945 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of COL6A1 mRNA | CTD | PMID:21551480 |
| doxorubicin | increases expression | ISO | RGD:1558231 | 6480464 | Doxorubicin results in increased expression of COL6A1 mRNA | CTD | PMID:15033991 |
| doxorubicin | multiple interactions | ISO | RGD:1558231 | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of COL6A1 mRNA | CTD | PMID:21040762 |
| folic acid | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA | CTD | PMID:20938992 |
| folic acid | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA | CTD | PMID:20548288 PMID:20938992 |
| genistein | increases expression | ISO | RGD:1352880 | 6480464 | Genistein results in increased expression of COL6A1 mRNA | CTD | PMID:23019147 |
| ionomycin | multiple interactions | ISO | RGD:1352880 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA; more ... | CTD | PMID:15477007 |
| isotretinoin | decreases expression | ISO | RGD:1352880 | 6480464 | Isotretinoin results in decreased expression of COL6A1 mRNA | CTD | PMID:15982314 |
| isotretinoin | increases expression | ISO | RGD:1352880 | 6480464 | Isotretinoin results in increased expression of COL6A1 mRNA | CTD | PMID:20436886 |
| L-methionine | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA | CTD | PMID:20938992 |
| L-methionine | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA | CTD | PMID:20548288 PMID:20938992 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of COL6A1 mRNA | CTD | PMID:11578147 |
| methotrexate | affects expression | ISO | RGD:1558231 | 6480464 | Methotrexate affects the expression of COL6A1 mRNA | CTD | PMID:18502557 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL6A1 mRNA; more ... | CTD | PMID:19840844 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1558231 | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of COL6A1 mRNA] | CTD | PMID:17942915 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1558231 | 6480464 | Diethylnitrosamine results in increased expression of COL6A1 mRNA | CTD | PMID:17942915 |
| okadaic acid | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL6A1 mRNA | CTD | PMID:19840844 |
| paclitaxel | increases expression | ISO | RGD:1352880 | 6480464 | Paclitaxel results in increased expression of COL6A1 mRNA | CTD | PMID:19682730 |
| phenytoin | decreases expression | ISO | RGD:1352880 | 6480464 | Phenytoin results in decreased expression of COL6A1 mRNA | CTD | PMID:14741686 |
| phenytoin | increases expression | ISO | RGD:1352880 | 6480464 | Phenytoin results in increased expression of COL6A1 mRNA | CTD | PMID:8224229 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1558231 | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL6A1 mRNA | CTD | PMID:19840844 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1352880 | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA] | CTD | PMID:15477007 |
| progesterone | decreases expression | ISO | RGD:1352880 | 6480464 | Progesterone results in decreased expression of COL6A1 mRNA | CTD | PMID:18070364 |
| quercetin | increases expression | ISO | RGD:1558231 | 6480464 | Quercetin results in increased expression of COL6A1 mRNA | CTD | PMID:16455785 |
| rosiglitazone | affects expression | ISO | RGD:1352880 | 6480464 | rosiglitazone affects the expression of COL6A1 protein | CTD | PMID:19556978 |
| Se-methyl-L-selenocysteine | increases expression | ISO | RGD:1352880 | 6480464 | selenomethylselenocysteine results in increased expression of COL6A1 mRNA | CTD | PMID:18514395 |
| Se-methylselenocysteine | increases expression | ISO | RGD:1352880 | 6480464 | selenomethylselenocysteine results in increased expression of COL6A1 mRNA | CTD | PMID:18514395 |
| selenomethionine | affects expression | ISO | RGD:1352880 | 6480464 | Selenomethionine affects the expression of COL6A1 mRNA | CTD | PMID:17222674 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of COL6A1 protein | CTD | PMID:19634143 |
| streptozocin | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A1 protein] | CTD | PMID:19634143 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1352880 | 6480464 | tert-Butylhydroperoxide results in increased expression of COL6A1 mRNA | CTD | PMID:15336504 |
| testosterone enanthate | affects expression | ISO | RGD:1352880 | 6480464 | testosterone enanthate affects the expression of COL6A1 mRNA | CTD | PMID:17440010 |
| topotecan | affects response to substance | ISO | RGD:1352880 | 6480464 | COL6A1 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 |
| tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of COL6A1 mRNA | CTD | PMID:21683754 |
| vancomycin | decreases expression | ISO | RGD:1558231 | 6480464 | Vancomycin results in decreased expression of COL6A1 mRNA | CTD | PMID:18930951 |